Charudatt Shirwadkar

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

Joel M. Dulhunty, Jason A. Roberts, Joshua S. Davis et al. · Clinical Infectious Diseases · 2012 · 392 citations · Full text

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis

Joel M. Dulhunty, Jason A. Roberts, Joshua S. Davis et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 261 citations

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis

Joel M. Dulhunty, Stephen J. Brett, Jan J. De Waele et al. · JAMA · 2024 · 107 citations · Full text

Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial

Andrew Udy, Joel M. Dulhunty, Jason A. Roberts et al. · International Journal of Antimicrobial Agents · 2017 · 104 citations · Full text

Antibiotics, Antimicrobial Stewardship, Clinical Epidemiology +9

<i>Acanthamoeba</i>Encephalitis in Patient with Systemic Lupus, India

Charudatt Shirwadkar, Rohini Samant, Milind Sankhe et al. · Emerging infectious diseases · 2006 · 50 citations · Full text